The significance of transient changes in trabecular bone remodeling activation
- PMID: 7980969
- DOI: 10.1016/8756-3282(94)90283-6
The significance of transient changes in trabecular bone remodeling activation
Abstract
After menopause, bone turnover is increased due to an increase in the activation of bone remodeling basic multicellular units (BMUs). The importance of changes in BMU activation to bone histomorphometry data and bone volume has not received adequate attention by many skeletal researchers. Therefore, the influence of BMU activation on the above parameters was modeled by way of computer simulation, and the results were compared to data from published post-menopausal bone loss studies. Using control theory concepts, the increase in BMU activation after menopause was modeled as a zero-, first-, or underdamped (oscillatory) second-order transient BMU activation response to the step input: the decline in estrogen. A computer simulation was developed to model the influence of these three transient BMU activation responses on quantitative histological surface parameters and bone volume. The transient BMU activation responses doubled the number of active BMUs. All three types of transient BMU activation responses produced a rapid 5% decline in bone volume due to increased remodeling space. Oscillations in bone volume and histologic surface parameters over time, similar in nature to those seen in studies of ovariectomized animals, were predicted by the simulation for the oscillatory activation response examined, underdamped second order. An oscillatory BMU activation response may explain some of the transient events during menopause. The increased coherence of BMUs created by such a response may increase the likelihood of trabecular perforations. the inherent nature of an oscillatory activation response may cause its detection to be overlooked and bone remodeling data to be misinterpreted.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Computer simulation of trabecular remodeling using a simplified structural model.Bone. 1999 Dec;25(6):733-9. doi: 10.1016/s8756-3282(99)00218-5. Bone. 1999. PMID: 10593419
-
Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis.Osteoporos Int. 2003;14 Suppl 3:S2-8. doi: 10.1007/s00198-002-1340-9. Epub 2003 Mar 19. Osteoporos Int. 2003. PMID: 12730770 Review.
-
A theoretical analysis of the changes in basic multicellular unit activity at menopause.Bone. 2003 Apr;32(4):357-63. doi: 10.1016/s8756-3282(03)00037-1. Bone. 2003. PMID: 12689678
-
Antiresorptive drugs and trabecular bone turnover: validation and testing of a computer model.Calcif Tissue Int. 1994 Mar;54(3):179-85. doi: 10.1007/BF00301675. Calcif Tissue Int. 1994. PMID: 8055363 Clinical Trial.
-
Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling.J Bone Miner Res. 2005 Feb;20(2):177-84. doi: 10.1359/JBMR.041114. Epub 2004 Nov 16. J Bone Miner Res. 2005. PMID: 15647810 Review.
Cited by
-
Dynamic simulation of three dimensional architectural and mechanical alterations in human trabecular bone during menopause.Bone. 2008 Aug;43(2):292-301. doi: 10.1016/j.bone.2008.04.008. Epub 2008 Apr 29. Bone. 2008. PMID: 18550463 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources